Menu

Mining the Tumor Microenvironment: Advanced Tools and Protocols for Tumor-Cell Signaling

The Scientist is bringing together a panel of experts to discuss the interplay of cells within the tumor microenvironment

Jul 31, 2017
The Scientist Creative Services Team

 

FREE Webinar

Thursday, September 7, 2017
2:30 - 4:00 p.m. EDT
Register Now

The tumor microenvironment forms a complex, privileged zone where conditions are permissive for unchecked tumor progression. Therein, both cancer and stromal cells exhibit aberrant growth and survival signaling, making pathway analyses ever-more difficult. Advanced tools have enabled deeper, more thorough investigation into how the tumor microenvironment has adapted to evade the immune system, and how we might counteract those adaptations. The Scientist is bringing together a panel of experts to discuss the interplay of cells within the tumor microenvironment and to share their latest methods and findings. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

Topics to be covered:

  • Studying pro-cancer signaling within the tumor niche
  • New assays for analyzing cell behavior and signaling within the tumor microenvironment

Register Now

Meet the Speakers:

Shijie Sheng, PhD
Professor, Departments of Pathology and Oncology
Wayne State University School of Medicine
Leader, Tumor Biology and Microenvironment Program,
Karamos Cancer Institute

 

Gagan Deep, PhD 
Associate Professor
Department of Cancer Biology
Wake Forest School of Medicine

 

 

 

 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.